GE vs NVCT · P/E 44, rev $13.35B vs $304.5M cap
GE Aerospace (GE) versus Nuvectis Pharma Inc (NVCT) — a side-by-side from cached financials, not a winner call.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
Nuvectis Pharma Inc (NVCT) is a biotechnology company listed on NASDAQ.
Latest reported GE revenue for 2026-06-30 was $13.35B. Net income was $2.37B. Revenue was up 7.7% from 2026-03-31 to 2026-06-30. GE currently screens at market cap $373.04B and trailing P/E 44.4.
NVCT does not have a complete income-statement cache yet.
GE currently screens at market cap $373.04B and trailing P/E 44.4. NVCT currently screens at market cap $304.5M.
Not investment advice. Open the GE and NVCT stock pages for the full models.
Not investment advice.